This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of pyriform sinus, including Hilmo
C3_PIRIFORMSINUS_WIDE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
50 |
4. Check minimum number of eventsNone |
50 |
5. Include endpointsNone |
50 |
6. Filter based on genotype QC (FinnGen only) |
49 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of pyriform sinus, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of hypopharynx, including Hilmo
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 49 | 6 | 43 |
| Unadjusted period prevalence (%) | 0.02 | 0.00 | 0.02 |
| Median age at first event (years) | 67.52 | 59.06 | 68.70 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 50
- Matched controls
- 500
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C12, ,
ICD-10 Finland
Malignant neoplasm of piriform sinus
+∞
56.3
43
*
J01DB01, ,
ATC
cefalexin; oral
+∞
49.4
39
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
49.4
39
*
A98, ,
ICD-O-3
+∞
46.2
37
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
44.6
36
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
38.6
32
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
38.6
32
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
37.2
31
*
130, ,
Kela drug reimbursment
Malignant tumour
+∞
37.2
31
*
GD1AA, ,
ICD-O-3
+∞
35.8
30
*
EB1HA, ,
ICD-O-3
+∞
34.4
29
*
S18, ,
ICD-O-3
+∞
33.0
28
*
WZC00, ,
ICD-O-3
+∞
33.0
28
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
31.6
27
*
WX110, ,
ICD-O-3
+∞
31.6
27
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
31.6
27
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
31.6
27
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
31.6
27
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
30.3
26
*
J01DA01, ,
ATC
[U] cefalexin
+∞
30.3
26
*
504, ,
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
+∞
27.7
24
*
JDB10, ,
ICD-O-3
+∞
27.7
24
*
SFA20, ,
ICD-O-3
+∞
26.4
23
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
26.4
23
*
UJC01, ,
ICD-O-3
+∞
26.4
23
*
WF002, ,
ICD-O-3
+∞
26.4
23
*
SAA01, ,
ICD-O-3
+∞
26.4
23
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
26.4
23
*
SPAT1256, ,
ICD-O-3
+∞
25.1
22
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
25.1
22
*
SAA03, ,
ICD-O-3
+∞
25.1
22
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
25.1
22
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
25.1
22
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
25.1
22
*
WZC30, ,
ICD-O-3
+∞
23.8
21
*
SAA02, ,
ICD-O-3
+∞
23.8
21
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
23.8
21
*
UJF32, ,
ICD-O-3
+∞
23.8
21
*
ZXD10, ,
ICD-O-3
+∞
23.8
21
*
C03CA01, ,
ATC
furosemide; systemic
+∞
22.6
20
*
WX290, ,
ICD-O-3
+∞
22.6
20
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
22.6
20
*
ZXE00, ,
ICD-O-3
+∞
22.6
20
*
K021, ,
ICD-O-3
+∞
21.4
19
*
SPAT1153, ,
ICD-O-3
+∞
21.4
19
*
ZXE10, ,
ICD-O-3
+∞
21.4
19
*
N05CF01, ,
ATC
zopiclone; oral
+∞
21.4
19
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
21.4
19
*
SFA10, ,
ICD-O-3
+∞
21.4
19
*
A06AD11, ,
ATC
lactulose; oral
+∞
21.4
19
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
21.4
19
*
I10, ,
ICD-O-3
+∞
20.1
18
*
ZXD05, ,
ICD-O-3
+∞
20.1
18
*
KMAK, ,
ICD-O-3
+∞
20.1
18
*
SFA30, ,
ICD-O-3
+∞
20.1
18
*
UJD10, ,
ICD-O-3
+∞
18.9
17
*
CJE20, ,
ICD-O-3
+∞
18.9
17
*
K021, ,
ICD-10 Finland
Caries of dentine
+∞
18.9
17
*
E0000UV, ,
ATC
+∞
18.9
17
*
WX408, ,
ICD-O-3
+∞
18.9
17
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
18.9
17
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
18.9
17
*
WX002, ,
ICD-O-3
+∞
18.9
17
*
EB1AA, ,
ICD-O-3
+∞
17.7
16
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
17.7
16
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
17.7
16
*
XX3DW, ,
ICD-O-3
+∞
17.7
16
*
C08CA01, ,
ATC
amlodipine; oral
+∞
17.7
16
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
17.7
16
*
WYA05, ,
ICD-O-3
+∞
17.7
16
*
Z871, ,
ICD-O-3
+∞
17.7
16
*
C129, 8070, 3
O3
+∞
17.7
16
*
WB103, ,
ICD-O-3
+∞
17.7
16
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
17.7
16
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
17.7
16
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
17.7
16
*
SPAT1263, ,
ICD-O-3
+∞
16.6
15
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
16.6
15
*
GD1QA, ,
ICD-O-3
+∞
16.6
15
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
16.6
15
*
SDA03, ,
ICD-O-3
+∞
16.6
15
*
M03BX02, ,
ATC
tizanidine; oral
+∞
16.6
15
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
16.6
15
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
16.6
15
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
16.6
15
*
Z012, ,
ICD-O-3
+∞
16.6
15
*
D07AC01, ,
ATC
betamethasone; topical
+∞
16.6
15
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
16.6
15
*
UDH02, ,
ICD-O-3
+∞
15.4
14
*
M02AA07, ,
ATC
piroxicam; topical
+∞
15.4
14
*
AA1AD, ,
ICD-O-3
+∞
15.4
14
*
C09AA05, ,
ATC
ramipril; oral
+∞
15.4
14
*
WZC20, ,
ICD-O-3
+∞
15.4
14
*
GDA98, ,
ICD-O-3
+∞
15.4
14
*
SDA02, ,
ICD-O-3
+∞
14.2
13
*
C10AA01, ,
ATC
simvastatin; oral
+∞
14.2
13
*
ZXA05, ,
ICD-O-3
+∞
14.2
13
*
WZB00, ,
ICD-O-3
+∞
14.2
13
*
UJC02, ,
ICD-O-3
+∞
14.2
13
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
14.2
13
*
EBA00, ,
ICD-O-3
+∞
14.2
13
*
WX402, ,
ICD-O-3
+∞
14.2
13
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
14.2
13
*
N05BA04, ,
ATC
oxazepam; oral
+∞
14.2
13
*
I702, ,
ICD-10 Finland
Atherosclerosis of arteries of extremities
+∞
14.2
13
*
SPAT1325, ,
ICD-O-3
+∞
14.2
13
*
SPAT1249, ,
ICD-O-3
+∞
14.2
13
*
R4110, ,
ICD-O-3
+∞
14.2
13
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
14.2
13
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
14.2
13
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
13.1
12
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
13.1
12
*
A10BA02, ,
ATC
metformin; oral
+∞
13.1
12
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
13.1
12
*
SPAT1310, ,
ICD-O-3
+∞
13.1
12
*
I48, ,
ICD-10 Finland
Atrial fibrillation and flutter
+∞
13.1
12
*
H02AB02, ,
ATC
dexamethasone; systemic
+∞
13.1
12
*
M04AA01, ,
ATC
allopurinol; systemic
+∞
13.1
12
*
EB1SA, ,
ICD-O-3
+∞
13.1
12
*
UDQ12, ,
ICD-O-3
+∞
13.1
12
*
R5110, ,
ICD-O-3
+∞
13.1
12
*
Z3231, ,
ICD-O-3
+∞
13.1
12
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
13.1
12
*
-1, ,
ICD-O-3
+∞
13.1
12
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
13.1
12
*
FM1EE, ,
ICD-O-3
+∞
13.1
12
*
SPAT1301, ,
ICD-O-3
+∞
13.1
12
*
A04AA01, ,
ATC
ondansetron; systemic, rectal
+∞
13.1
12
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
13.1
12
*
R05, ,
ICD-O-3
+∞
13.1
12
*
SPAT1223, ,
ICD-O-3
+∞
11.9
11
*
JN3AE, ,
ICD-O-3
+∞
11.9
11
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
11.9
11
*
L17, ,
ICD-O-3
+∞
11.9
11
*
EP1AE, ,
ICD-O-3
+∞
11.9
11
*
B01AA03, ,
ATC
warfarin; systemic
+∞
11.9
11
*
SCA01, ,
ICD-O-3
+∞
11.9
11
*
C139, ,
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
+∞
11.9
11
*
L03, ,
ICD-O-3
+∞
11.9
11
*
D82, ,
ICD-O-3
+∞
11.9
11
*
R06AE07, ,
ATC
cetirizine; oral
+∞
11.9
11
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
11.9
11
*
UKC02, ,
ICD-O-3
+∞
11.9
11
*
JN4BD, ,
ICD-O-3
+∞
11.9
11
*
N03AX16, ,
ATC
[U] pregabalin
+∞
11.9
11
*
GD1UA, ,
ICD-O-3
+∞
11.9
11
*
D07AC13, ,
ATC
mometasone; topical
+∞
11.9
11
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
11.9
11
*
TPH04, ,
ICD-O-3
+∞
11.9
11
*
I509, ,
ICD-10 Finland
Heart failure, unspecified
+∞
11.9
11
*
SPAT1262, ,
ICD-O-3
+∞
10.8
10
*
JN3BD, ,
ICD-O-3
+∞
10.8
10
*
Z515, ,
ICD-10 Finland
Palliative care
+∞
10.8
10
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
10.8
10
*
Z024, ,
ICD-O-3
+∞
10.8
10
*
FN1AC, ,
ICD-O-3
+∞
10.8
10
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
10.8
10
*
FM1AE, ,
ICD-O-3
+∞
10.8
10
*
I48, ,
ICD-O-3
+∞
10.8
10
*
ZXA00, ,
ICD-O-3
+∞
10.8
10
*
R21, ,
ICD-O-3
+∞
10.8
10
*
JN4AD, ,
ICD-O-3
+∞
10.8
10
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
10.8
10
*
SDA01, ,
ICD-O-3
+∞
10.8
10
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
10.8
10
*
A28, ,
ICD-O-3
+∞
10.8
10
*
R2130, ,
ICD-O-3
+∞
10.8
10
*
N06AB10, ,
ATC
escitalopram; oral
+∞
10.8
10
*
EBA15, ,
ICD-O-3
+∞
10.8
10
*
N40, ,
ICD-10 Finland
Hyperplasia of prostate
+∞
10.8
10
*
GD1BD, ,
ICD-O-3
+∞
10.8
10
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
10.8
10
*
C01DA14, ,
ATC
isosorbide mononitrate; oral
+∞
10.8
10
*
SPAT1253, ,
ICD-O-3
+∞
10.8
10
*
Z712, ,
ICD-O-3
+∞
9.7
9
*
K045, ,
ICD-10 Finland
Chronic apical periodontitis
+∞
9.7
9
*
EBA10, ,
ICD-O-3
+∞
9.7
9
*
D107, ,
ICD-10 Finland
Benign neoplasm: Hypopharynx
+∞
9.7
9
*
EBA05, ,
ICD-O-3
+∞
9.7
9
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
9.7
9
*
B01AC04, ,
ATC
clopidogrel; oral
+∞
9.7
9
*
XF400, ,
ICD-O-3
+∞
9.7
9
*
EN1BD, ,
ICD-O-3
+∞
9.7
9
*
N02AB03, ,
ATC
fentanyl; nasal, sublingual, transdermal
+∞
9.7
9
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
9.7
9
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
9.7
9
*
H13, ,
ICD-O-3
+∞
9.7
9
*
Z2221, ,
ICD-O-3
+∞
9.7
9
*
SFC01, ,
ICD-O-3
+∞
9.7
9
*
JN5DR, ,
ICD-O-3
+∞
9.7
9
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
9.7
9
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
9.7
9
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
9.7
9
*
T90, ,
ICD-O-3
+∞
9.7
9
*
N05BA01, ,
ATC
diazepam; systemic, rectal
+∞
9.7
9
*
ZXA10, ,
ICD-O-3
+∞
8.6
8
*
A04AA02, ,
ATC
granisetron; systemic, transdermal
+∞
8.6
8
*
UGC12, ,
ICD-O-3
+∞
8.6
8
*
R13, ,
ICD-10 Finland
Dysphagia
+∞
8.6
8
*
GD1AD, ,
ICD-O-3
+∞
8.6
8
*
WX404, ,
ICD-O-3
+∞
8.6
8
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
8.6
8
*
I252, ,
ICD-10 Finland
Old myocardial infarction
+∞
8.6
8
*
Z3226, ,
ICD-O-3
+∞
8.6
8
*
SFA40, ,
ICD-O-3
+∞
8.6
8
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
8.6
8
*
R229, ,
ICD-O-3
+∞
8.6
8
*
SPAT1053, ,
ICD-O-3
+∞
8.6
8
*
M01AX17, ,
ATC
nimesulide; oral
+∞
8.6
8
*
L28, ,
ICD-O-3
+∞
8.6
8
*
H02AB07, ,
ATC
prednisone; oral
+∞
8.6
8
*
SPAT1250, ,
ICD-O-3
+∞
8.6
8
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
8.6
8
*
D649, ,
ICD-10 Finland
Anaemia, unspecified
+∞
8.6
8
*
SPAT1222, ,
ICD-O-3
+∞
8.6
8
*
R4190, ,
ICD-O-3
+∞
8.6
8
*
WX105, ,
ICD-O-3
+∞
8.6
8
*
DFF00, ,
ICD-O-3
+∞
8.6
8
*
JCA55, ,
ICD-O-3
+∞
8.6
8
*
TQW40, ,
ICD-O-3
+∞
8.6
8
*
C07AA05, ,
ATC
propranolol; systemic
+∞
8.6
8
*
SPAT1312, ,
ICD-O-3
+∞
8.6
8
*
PH2AE, ,
ICD-O-3
+∞
8.6
8
*
D01BA02, ,
ATC
terbinafine; oral
+∞
8.6
8
*
206, ,
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
+∞
8.6
8
*
K045, ,
ICD-O-3
+∞
8.6
8
*
WW200, ,
ICD-O-3
+∞
7.5
7
*
JN3AA, ,
ICD-O-3
+∞
7.5
7
*
QAE10, ,
ICD-O-3
+∞
7.5
7
*
R238, ,
ICD-O-3
+∞
7.5
7
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
7.5
7
*
C03DA01, ,
ATC
spironolactone; oral
+∞
7.5
7
*
GD1PA, ,
ICD-O-3
+∞
7.5
7
*
SPAT1254, ,
ICD-O-3
+∞
7.5
7
*
J448, ,
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
+∞
7.5
7
*
XCW99, ,
ICD-O-3
+∞
7.5
7
*
N05AH04, ,
ATC
quetiapine; oral
+∞
7.5
7
*
L15, ,
ICD-O-3
+∞
7.5
7
*
D128, ,
ICD-10 Finland
Benign neoplasm: Rectum
+∞
7.5
7
*
I259, ,
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
+∞
7.5
7
*
SCA02, ,
ICD-O-3
+∞
7.5
7
*
C12, ,
ICD-O-3
Pyriform sinus
+∞
7.5
7
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
7.5
7
*
S21, ,
ICD-O-3
+∞
7.5
7
*
207, ,
Kela drug reimbursment
Chronic arrhythmias
+∞
7.5
7
*
E000001, ,
ATC
+∞
7.5
7
*
A03, ,
ICD-O-3
+∞
7.5
7
*
N06AB04, ,
ATC
citalopram; systemic
+∞
7.5
7
*
R03BB04, ,
ATC
tiotropium bromide; inhalant
+∞
7.5
7
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
7.5
7
*
C139, 8070, 3
O3
+∞
7.5
7
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
7.5
7
*
D19, ,
ICD-O-3
+∞
7.5
7
*
WX700, ,
ICD-O-3
+∞
7.5
7
*
SDA04, ,
ICD-O-3
+∞
7.5
7
*
M01AC01, ,
ATC
piroxicam; systemic, rectal
+∞
7.5
7
*
EP1CG, ,
ICD-O-3
+∞
7.5
7
*
C09AA02, ,
ATC
enalapril; systemic
+∞
7.5
7
*
SPAT1097, ,
ICD-O-3
+∞
7.5
7
*
M545, ,
ICD-O-3
+∞
7.5
7
*
R600, ,
ICD-O-3
+∞
7.5
7
*
T810, ,
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
+∞
7.5
7
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
7.5
7
*
M511, ,
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
+∞
7.5
7
*
290, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
7.5
7
*
L08, ,
ICD-O-3
+∞
7.5
7
*
C09CA06, ,
ATC
candesartan; oral
+∞
7.5
7
*
SDE02, ,
ICD-O-3
+∞
7.5
7
*
H81, ,
ICD-O-3
+∞
7.5
7
*
R01AD09, ,
ATC
mometasone; nasal
+∞
7.5
7
*
K0365, ,
ICD-O-3
+∞
7.5
7
*
S29, ,
ICD-O-3
+∞
7.5
7
*
D07XC01, ,
ATC
betamethasone; topical
+∞
7.5
7
*
C770, ,
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
7.5
7
*
A04AA55, ,
ATC
palonosetron, combinations; systemic
+∞
7.5
7
*
UDQ22, ,
ICD-O-3
+∞
7.5
7
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
6.4
6
*
C138, ,
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of hypopharynx
+∞
6.4
6
*
M472, ,
ICD-10 Finland
Other spondylosis with radiculopathy
+∞
6.4
6
*
C03EA01, ,
ATC
hydrochlorothiazide and potassium-sparing agents; oral
+∞
6.4
6
*
I639, ,
ICD-10 Finland
Cerebral infarction, unspecified
+∞
6.4
6
*
351, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
6.4
6
*
D141, ,
ICD-10 Finland
Benign neoplasm: Larynx
+∞
6.4
6
*
R221, ,
ICD-10 Finland
Localized swelling, mass and lump, neck
+∞
6.4
6
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
6.4
6
*
P06, ,
ICD-O-3
+∞
6.4
6
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
6.4
6
*
C131, ,
ICD-10 Finland
Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect
+∞
6.4
6
*
M171, ,
ICD-10 Finland
Other primary gonarthrosis
+∞
6.4
6
*
N05CD07, ,
ATC
temazepam; oral
+∞
6.4
6
*
WX320, ,
ICD-O-3
+∞
6.4
6
*
D01, ,
ICD-O-3
+∞
6.4
6
*
L01BC06, ,
ATC
capecitabine; oral
+∞
6.4
6
*
KC1EE, ,
ICD-O-3
+∞
6.4
6
*
A97, ,
ICD-O-3
+∞
6.4
6
*
WX872, ,
ICD-O-3
+∞
6.4
6
*
XKD00, ,
ICD-O-3
+∞
6.4
6
*
I500, ,
ICD-10 Finland
Congestive heart failure
+∞
6.4
6
*
N40, ,
ICD-O-3
+∞
6.4
6
*
I351, ,
ICD-10 Finland
Aortic (valve) insufficiency
+∞
6.4
6
*
Z508, ,
ICD-10 Finland
Care involving use of other rehabilitation procedures
+∞
6.4
6
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
6.4
6
*
M796, ,
ICD-O-3
+∞
6.4
6
*
D125, ,
ICD-10 Finland
Benign neoplasm: Sigmoid colon
+∞
6.4
6
*
VALMI, ,
ICD-O-3
+∞
6.4
6
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
6.4
6
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
6.4
6
*
SPAT1033, ,
ICD-O-3
+∞
6.4
6
*
Z769, ,
ICD-10 Finland
Person encountering health services in unspecified circumstances
+∞
6.4
6
*
D07BC01, ,
ATC
betamethasone and antiseptics; topical
+∞
6.4
6
*
WX100, ,
ICD-O-3
+∞
6.4
6
*
L13, ,
ICD-O-3
+∞
6.4
6
*
C329, 8070, 3
O3
+∞
6.4
6
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
6.4
6
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
6.4
6
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
6.4
6
*
SGB10, ,
ICD-O-3
+∞
6.4
6
*
E118, ,
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
+∞
6.4
6
*
F101, ,
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
+∞
6.4
6
*
Z000, ,
ICD-10 Finland
General medical examination
+∞
6.4
6
*
R101, ,
ICD-10 Finland
Pain localized to upper abdomen
+∞
6.4
6
*
C09CA01, ,
ATC
losartan; oral
+∞
6.4
6
*
M01AH02, ,
ATC
rofecoxib; oral
+∞
6.4
6
*
NH3AA, ,
ICD-O-3
+∞
6.4
6
*
M480, ,
ICD-10 Finland
Spinal stenosis
+∞
6.4
6
*
T814, ,
ICD-10 Finland
Infection following a procedure, not elsewhere classified
+∞
6.4
6
*
E119, ,
ICD-O-3
+∞
6.4
6
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
6.4
6
*
YA1AD, ,
ICD-O-3
+∞
6.4
6
*
C61, ,
ICD-10 Finland
Malignant neoplasm of prostate
+∞
6.4
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
25
77
5.49
8.21
3.9
2.0
—
—
—
0
0
17
26
9.32
8.00
2.7
2.5
0.19
0.19
g/l
0.04
17
19
33
145
4.75
6.64
3.9
2.2
—
—
—
0
0
14
25
7.34
5.92
1.4
1.1
—
—
—
0
0
8
5
18.61
5.61
1.6
1.0
—
—
—
0
0
29
141
3.52
4.55
7.9
3.9
33.38
34.82
g/l
0.64
29
132
34
203
3.11
3.47
26.1
15.1
1.36
1.42
inr
—
10
39
10
25
4.73
3.30
1.6
1.6
—
—
—
0
0
14
54
3.21
3.01
1.9
1.7
—
—
—
0
0
12
43
3.36
2.88
6.0
7.4
102.67
104.77
mmol/l
0.57
12
43
15
62
3.03
2.87
6.4
2.2
2.47
2.44
mmol/l
0.71
15
57
8
20
4.55
2.70
1.4
1.3
—
—
—
0
0
7
17
4.60
2.46
1.6
1.4
—
—
—
0
0
33
218
2.51
2.40
7.5
4.6
6.91
7.08
mmol/l
0.16
33
204
13
55
2.84
2.36
2.7
2.5
12.02
12.25
umol/l
0.05
13
50
7
18
4.34
2.35
1.6
1.5
—
—
—
0
0
16
79
2.51
2.15
2.0
1.9
3.72
2.81
mg/l
0.66
11
65
11
49
2.60
1.79
2.8
2.4
19.43
22.36
%
0.39
11
44
23
153
1.93
1.41
2.1
2.0
83.94
89.82
pmol/l
0.26
16
90
19
124
1.86
1.20
3.2
2.9
—
—
—
0
0
7
35
2.16
1.05
5.3
2.6
—
—
—
0
0
7
37
2.03
0.98
2.1
1.6
—
—
—
0
0
6
32
1.99
0.85
4.7
2.1
8.50
8.06
umol/l
—
6
27
5
27
1.94
0.70
6.8
1.7
28.80
31.06
u/l
—
5
18
33
373
0.66
0.60
3.4
4.1
1.10
1.28
mmol/l
1.11
28
335
6
35
1.81
0.60
2.2
1.7
—
—
—
0
0
34
382
0.66
0.60
3.7
4.7
3.99
4.35
mmol/l
1.03
29
352
34
381
0.66
0.58
3.7
4.6
1.40
1.35
mmol/l
0.22
28
345
16
120
1.49
0.55
1.9
2.2
77.56
293.95
u/l
3.32
16
111
11
81
1.46
0.40
6.9
3.1
32.09
241.13
ng/l
1.77
11
68
24
205
1.33
0.38
5.3
3.5
22.92
25.42
%
0.19
11
98
36
390
0.73
0.37
4.3
5.3
2.17
2.56
mmol/l
1.69
29
354
6
43
1.45
0.36
1.5
2.7
6.68
12.18
ug/l
—
6
36
35
375
0.78
0.26
5.2
4.9
5.99
6.27
mmol/l
0.92
30
329
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
156.51
—
0
10
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
19
168
1.21
0.19
2.4
2.6
—
—
—
0
0
19
173
1.16
0.13
3.4
3.5
18.86
69.18
ng/l
1.83
14
130
40
410
0.88
0.06
44.2
18.2
126.90
139.59
g/l
4.22
40
401
40
392
1.10
0.03
37.3
15.7
137.88
139.73
mmol/l
2.61
40
378
13
122
1.09
0.03
2.7
3.5
—
—
—
0
0
36
368
0.92
0.03
5.7
6.8
39.60
41.43
mmol/mol
0.64
30
335
26
267
0.95
0.01
5.9
3.7
5.26
2.02
ug/l
0.52
26
240
40
396
1.05
0.00
37.2
14.8
88.67
87.53
umol/l
0.04
40
396
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PIRIFORMSINUS_WIDE – Malignant neoplasm of pyriform sinus, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).